Clinical trial
A Triple-Blind Randomised Clinical Trial on the Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy
NCT07162454 is registered in ClinicalTrials.gov with Universidad Complutense de Madrid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Triple-Blind Randomised Clinical Trial on the Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy
- Lead sponsor
- Universidad Complutense de Madrid
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2024
- Completion date
- June 30, 2025
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuropathic pain associated with diabetic peripheral neuropathy, xerosis cutis